SRSF6 and thyroid gland undifferentiated (anaplastic) carcinoma: NSUN2-mediated m5C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis